Medicine
Cabtreo 1.5 mg/31 mg/12 mg per g gel
Cabtreo 1.5 mg/31 mg/12 mg per g gel is a prescription medicine containing Adapalene, Benzoyl peroxide and Clindamycin for topical use, marketed by Bausch Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store CABTREO in a refrigerator between 2° to 8°C (36° to 46°F) until…
Key facts
- Active ingredient (INN)
- Adapalene, Benzoyl peroxide and Clindamycin
- Brand
- Cabtreo
- Strength
- 1.5 mg/31 mg/12 mg per g
- Dosage form
- Gel
- Route
- Topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Bausch Health
- Manufacturer
- Bausch Health
- Origin register
- US FDA, United States
- Storage
- Store CABTREO in a refrigerator between 2° to 8°C (36° to 46°F) until dispensed to the patient. Do not freeze. After Dispensing: Store CABTREO at room temperature at or below 25°C (77°F). Store pump upright.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 October 2023
- Identifiers
- RxCUI 2668198, 2668204DailyMed set ID 9468da0f-9978-4c58-8135-0274c3415084NDC 0187-0006Application NDA216632
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 20 g in 1 bottle, pump | 0187-0006-10 | Bausch Health | 20 October 2023 |
| 1 bottle, pump in 1 carton / 50 g in 1 bottle, pump | 0187-0006-25 | Bausch Health | 20 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 20 October 2023 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Adapalene, Benzoyl peroxide and Clindamycin is a fixed-dose combination of a lincosamide antibacterial and a retinoid indicated for the topical treatment of acne vulgaris in adult, among other approved uses. MedsAcross supplies Adapalene, Benzoyl peroxide and Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Adapalene, Benzoyl peroxide and ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cabtreo prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Cabtreo 1.5 mg/31 mg/12 mg per g gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.